-transparent.png){kind=logo}
Iso-volume FEF25-75% was evaluated in 30 non-smoking, healthy subjects (16-58 years) to define the percentage change over baseline required for responsiveness to inhaled bronchodilators using this measurement to be significant. The mean percentage change from baseline for Iso-volume FEF25-75% was 15.3% +/- 17.2% (1 SD). Improvement of greater than 49.6% (mean +/- 2 SD) over baseline is required for the change reflected by the Iso-volume FEF25-75% to be significant.
Related Publications
P B Boggs, and
K D Bhat, and
W A Vekovius, and
M S Debo
March 1978,
The American review of respiratory disease,
P B Boggs, and
K D Bhat, and
W A Vekovius, and
M S Debo
June 1986,
Chest,
P B Boggs, and
K D Bhat, and
W A Vekovius, and
M S Debo
May 1969,
Review of allergy,
P B Boggs, and
K D Bhat, and
W A Vekovius, and
M S Debo
October 1980,
Chest,
P B Boggs, and
K D Bhat, and
W A Vekovius, and
M S Debo
December 1990,
Acta medica Okayama,
P B Boggs, and
K D Bhat, and
W A Vekovius, and
M S Debo
January 1972,
Plucne bolesti i tuberkuloza,
P B Boggs, and
K D Bhat, and
W A Vekovius, and
M S Debo
September 1975,
The American review of respiratory disease,
P B Boggs, and
K D Bhat, and
W A Vekovius, and
M S Debo
January 1973,
Scandinavian journal of respiratory diseases,
P B Boggs, and
K D Bhat, and
W A Vekovius, and
M S Debo
January 2015,
PloS one,
P B Boggs, and
K D Bhat, and
W A Vekovius, and
M S Debo
January 1989,
Respiration; international review of thoracic diseases,
